A Phase II Trial of Prostate-Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane-Refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Journal of Clinical Oncology- United States

doi 10.1200/jco.2014.32.4_suppl.83

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society of Clinical Oncology (ASCO)

Related search

Prostate-Specific Membrane Antigen Based Antibody-Drug Conjugates for Metastatic Castration-Resistance Prostate Cancer

Cureus
2020English

Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer

Cancer Journal
Cancer ResearchOncology
2016English

Phase II Trial of Cisplatin Plus Prednisone in Docetaxel-Refractory Castration-Resistant Prostate Cancer Patients

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2011English

Results of a Phase I/Ii Clinical Trial of BPX-101, a Novel Drug-Activated Dendritic Cell (DC) Vaccine for Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

225Ac-Psma-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Influence of Enzalutamide on Cabazitaxel Pharmacokinetics; A Drug-Drug Interaction Study in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients

Clinical Cancer Research
Cancer ResearchOncology
2017English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) With Docetaxel in Metastatic Castration‐Resistant Prostate Cancer (mCRPC)

Oncologist
Cancer ResearchMedicineOncology
2019English

Molecular Profiling Stratifies Diverse Phenotypes of Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer

Journal of Clinical Investigation
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy